New ultrasound method could predict relapses in rare artery disease
NCT ID NCT07552636
First seen Apr 30, 2026 · Last updated Jun 23, 2026 · Updated 5 times
Summary
This study tests whether ultrasound scans and patient questionnaires can better track disease activity in people with giant cell arteritis, a condition that inflames arteries and can cause blindness. Researchers will follow 175 patients in remission for one year, using ultrasound and blood samples to see if they can predict relapses. The goal is to improve monitoring and reduce reliance on steroids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aalborg University Hospital, Department of Rheumatology
NOT_YET_RECRUITINGAalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aarhus University Hospital, Department of Rheumatology
NOT_YET_RECRUITINGAarhus, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospitalsenhed Midt, Medicinsk Diagnostisk Center
NOT_YET_RECRUITINGSilkeborg, 8600, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Regional Hospital Horsens, Department of Medicine
RECRUITINGHorsens, 8700, Denmark
Contact Email: •••••@•••••
-
Rigshospitalet Glostrup, Center for Rheumatology and Spine Diseases Rigshospitalet
NOT_YET_RECRUITINGGlostrup Municipality, 2600, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Svendborg Hospital, Department of Medicine
NOT_YET_RECRUITINGSvendborg, 5700, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vejle Hospital, Department of Medicine
NOT_YET_RECRUITINGVejle, 7100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better tools for monitoring giant cell arteritis and predicting relapses, helping doctors tailor treatments and reduce long-term steroid use.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. The tools tested may not prove reliable enough for routine use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.